Epithelial Endoplasmic Reticulum Stress Enhances the Risk of Muc5b-associated Lung Fibrosis

The gain-of-function minor allele of the MUC5B (mucin 5B, oligomeric mucus/gel-forming) promoter (rs35705950) is the strongest risk factor for idiopathic pulmonary fibrosis (IPF), a devastating fibrotic lung disease that leads to progressive respiratory failure in adults. We have previously demonstrated that Muc5b overexpression in mice worsens lung fibrosis after bleomycin exposure and have hypothesized that excess Muc5b promotes endoplasmic reticulum (ER) stress and apoptosis, stimulating fibrotic lung injury. Here, we report that ER stress pathway members ATF4 (activating transcription factor 4) and ATF6 coexpress with MUC5B in epithelia of the distal IPF airway and honeycomb cyst and that this is more pronounced in carriers of the gain-of-function MUC5B promoter variant. Similarly, in mice exposed to bleomycin, Muc5b expression is temporally associated with markers of ER stress. Using bulk and single-cell RNA sequencing in bleomycin-exposed mice, we found that pathologic ER stress–associated transcripts Atf4 and Ddit3 (DNA damage inducible transcript 3) were elevated in alveolar epithelia of SFTPC-Muc5b transgenic (SFTPC-Muc5bTg) mice relative to wild-type (WT) mice. Activation of the ER stress response inhibits protein translation for most genes by phosphorylation of Eif2α (eukaryotic translation initiation factor 2 alpha), which prevents guanine exchange by Eif2B and facilitates translation of Atf4. The integrated stress response inhibitor (ISRIB) facilitates interaction of phosphorylated Eif2α with Eif2B, overcoming translation inhibition associated with ER stress and reducing Atf4. We found that a single dose of ISRIB diminished Atf4 translation in SFTPC-Muc5bTg mice after bleomycin injury. Moreover, ISRIB resolved the exaggerated fibrotic response of SFTPC-Muc5bTg mice to bleomycin. In summary, we demonstrate that MUC5B and Muc5b expression is associated with pathologic ER stress and that restoration of normal translation with a single dose of ISRIB promotes lung repair in bleomycin-injured Muc5b-overexpressing mice.

Correspondence and requests for reprints should be addressed to David A. Schwartz, M.D., University of Colorado, 12700 East 19th Avenue, Aurora, CO 80045. E-mail:
.

*Co–first authors.

‡Co–senior authors.

Supported by Francis Family Foundation grant AWD-191474 (J.S.K.), National Heart, Lung, and Blood Institute Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship F32-HL154666 (E.K.), and U.S. Department of Defense award DoD W81XWH-16-PRMRP-FPA (principal investigator, D.A.S.; project 4 project director, I.V.Y.).

Author Contributions: I.V.Y. and D.A.S. secured funding for this project and supervised the research. E.D., C.E.H., J.S.K., E.K., A.M,E., I.V.Y., and D.A.S. conceived of experiments. E.D., C.E.H., J.S.K., E.K., A.M.E., and I.V.Y. performed experiments. E.D. and J.S.K. drafted the manuscript. E.D., J.S.K., E.K., I.V.Y., and D.A.S. edited the manuscript.

This article has a related editorial.

This article has a data supplement, which is accessible from this issue’s table of contents at www.atsjournals.org.

Originally Published in Press as DOI: 10.1165/rcmb.2022-0252OC on September 15, 2022

Author disclosures are available with the text of this article at www.atsjournals.org.

留言 (0)

沒有登入
gif